A Randomized, Double-Blind, Placebo-Controlled Trial (RDBPCT) of the Effectiveness of the Lidocaine Patch in the Management of Neuropathic Pain After Breast Cancer Surgery.
Phase of Trial: Phase IV
Latest Information Update: 05 Jul 2018
At a glance
- Drugs Lidocaine (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 21 Mar 2012 Planned End Date changed from 1 Dec 2009 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 21 Mar 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.